000 01660 a2200445 4500
005 20250515090453.0
264 0 _c20071221
008 200712s 0 0 eng d
022 _a1349-7006
024 7 _a10.1111/j.1349-7006.2007.00624.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKawaguchi, Wakae
245 0 0 _aSimultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma.
_h[electronic resource]
260 _bCancer science
_cDec 2007
300 _a2002-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
650 0 4 _aAnnexin A5
_xanalysis
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMitogen-Activated Protein Kinase Kinases
_xantagonists & inhibitors
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xtherapeutic use
650 0 4 _aPhosphoinositide-3 Kinase Inhibitors
700 1 _aItamochi, Hiroaki
700 1 _aKigawa, Junzo
700 1 _aKanamori, Yasunobu
700 1 _aOishi, Tetsuro
700 1 _aShimada, Muneaki
700 1 _aSato, Sinya
700 1 _aShimogai, Ruri
700 1 _aSato, Seiya
700 1 _aTerakawa, Naoki
773 0 _tCancer science
_gvol. 98
_gno. 12
_gp. 2002-8
856 4 0 _uhttps://doi.org/10.1111/j.1349-7006.2007.00624.x
_zAvailable from publisher's website
999 _c17422561
_d17422561